SP

Satyanarayana Palukuri

Director Director DIN 03058685
DIN 03058685 First appointment May 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Satyanarayana Palukuri

Data last updated:

Satyanarayana Palukuri was a Director at Seelam Laboratories Private Limited (2010–2016) and Director at Orange Bio Pharmaceuticals Private Limited (from 2010). The companies operate in Pharma.

DIN 03058685
Primary Designation Director
Industry Pharma
First Appointment 20 May 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Seelam Laboratories Private Limited U24232TG2010PTC068611
Director28 May 20102010₹9.84 Cr (FY 2024)Active
Director20 May 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Orange Bio Pharmaceuticals Private Limited
Seelam Laboratories Private Limited
Premium access

Shareholding and investment profile for Satyanarayana Palukuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satyanarayana Palukuri

Satyanarayana Palukuri was first appointed on 20 May 2010 as Director at Orange Bio Pharmaceuticals Private Limited.

Satyanarayana Palukuri held 2 earlier board appointments: Seelam Laboratories Private Limited (Director, 28 May 2010 to 20 Jul 2016); Orange Bio Pharmaceuticals Private Limited (Director, from 20 May 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available